NRT-6008

钇90炭微球

Report date: 2026/04/30 20:00:20
NME

Base Information

Drug NameNRT-6008
Drug Alias NameNRT6008NRT-6008
ClassificationRadiation-emitting products > Nuclides > Yttrium > 90YSmall moleculesRadiation-emitting products > Radioactive therapeutic agent
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesChengdu New Radiomedicinetechnology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesChengdu New Radiomedicinetechnology Co LtdNRT MedTech Australia Pty LtdChongqing Huapont Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsPancreatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A